174 related articles for article (PubMed ID: 26331238)
1. Histone deacetylase inhibitors promote the expression of ATP2A3 gene in breast cancer cell lines.
Contreras-Leal E; Hernández-Oliveras A; Flores-Peredo L; Zarain-Herzberg Á; Santiago-García J
Mol Carcinog; 2016 Oct; 55(10):1477-85. PubMed ID: 26331238
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitors promote ATP2A3 gene expression in hepatocellular carcinoma cells: p300 as a transcriptional regulator.
Hernández-Oliveras A; Izquierdo-Torres E; Meneses-Morales I; Rodríguez G; Zarain-Herzberg Á; Santiago-García J
Int J Biochem Cell Biol; 2019 Aug; 113():8-16. PubMed ID: 31146004
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol up-regulates ATP2A3 gene expression in breast cancer cell lines through epigenetic mechanisms.
Izquierdo-Torres E; Hernández-Oliveras A; Meneses-Morales I; Rodríguez G; Fuentes-García G; Zarain-Herzberg Á
Int J Biochem Cell Biol; 2019 Aug; 113():37-47. PubMed ID: 31173924
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation of the human ATP2A3 gene promoter in gastric and colon cancer cell lines.
Meneses-Morales I; Izquierdo-Torres E; Flores-Peredo L; Rodríguez G; Hernández-Oliveras A; Zarain-Herzberg Á
Mol Carcinog; 2019 Jun; 58(6):887-897. PubMed ID: 30657210
[TBL] [Abstract][Full Text] [Related]
5. Induction of cell differentiation activates transcription of the Sarco/Endoplasmic Reticulum calcium-ATPase 3 gene (ATP2A3) in gastric and colon cancer cells.
Flores-Peredo L; Rodríguez G; Zarain-Herzberg A
Mol Carcinog; 2017 Feb; 56(2):735-750. PubMed ID: 27433831
[TBL] [Abstract][Full Text] [Related]
6. ATP2A3 gene as an important player for resveratrol anticancer activity in breast cancer cells.
Izquierdo-Torres E; Rodríguez G; Meneses-Morales I; Zarain-Herzberg A
Mol Carcinog; 2017 Jul; 56(7):1703-1711. PubMed ID: 28150875
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation of claudin-6 promotes breast cancer cell migration and invasion by recruiting MeCP2 and deacetylating H3Ac and H4Ac.
Liu Y; Jin X; Li Y; Ruan Y; Lu Y; Yang M; Lin D; Song P; Guo Y; Zhao S; Dong B; Xie Y; Dang Q; Quan C
J Exp Clin Cancer Res; 2016 Jul; 35(1):120. PubMed ID: 27461117
[TBL] [Abstract][Full Text] [Related]
8. Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells.
Yang X; Phillips DL; Ferguson AT; Nelson WG; Herman JG; Davidson NE
Cancer Res; 2001 Oct; 61(19):7025-9. PubMed ID: 11585728
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic mechanisms regulate the prostaglandin E receptor 2 in breast cancer.
To SQ; Takagi K; Miki Y; Suzuki K; Abe E; Yang Y; Sasano H; Simpson ER; Knower KC; Clyne CD
J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):331-8. PubMed ID: 22929011
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitors induce the expression of tumor suppressor genes Per1 and Per2 in human gastric cancer cells.
Hernández-Rosas F; Hernández-Oliveras A; Flores-Peredo L; Rodríguez G; Zarain-Herzberg Á; Caba M; Santiago-García J
Oncol Lett; 2018 Aug; 16(2):1981-1990. PubMed ID: 30008892
[TBL] [Abstract][Full Text] [Related]
11. ATP2A3 gene is involved in cancer susceptibility.
Korosec B; Glavac D; Volavsek M; Ravnik-Glavac M
Cancer Genet Cytogenet; 2009 Jan; 188(2):88-94. PubMed ID: 19100511
[TBL] [Abstract][Full Text] [Related]
12. Regulation of estrogen receptor β1 expression in breast cancer by epigenetic modification of the 5' regulatory region.
Al-Nakhle H; Smith L; Bell SM; Burns PA; Cummings M; Hanby AM; Lane S; Parker MD; Hughes TA; Speirs V
Int J Oncol; 2013 Dec; 43(6):2039-45. PubMed ID: 24068253
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional repression of ErbB2 by histone deacetylase inhibitors detected by a genomically integrated ErbB2 promoter-reporting cell screen.
Scott GK; Marden C; Xu F; Kirk L; Benz CC
Mol Cancer Ther; 2002 Apr; 1(6):385-92. PubMed ID: 12477051
[TBL] [Abstract][Full Text] [Related]
14. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H; Kim JH; Lee YS; Lee YC
Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
[TBL] [Abstract][Full Text] [Related]
15. Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation.
Wu Y; Alvarez M; Slamon DJ; Koeffler P; Vadgama JV
BMC Cancer; 2010 Feb; 10():32. PubMed ID: 20132554
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
[TBL] [Abstract][Full Text] [Related]
17. TRPM2 mediates histone deacetylase inhibition-induced apoptosis in bladder cancer cells.
Cao QF; Qian SB; Wang N; Zhang L; Wang WM; Shen HB
Cancer Biother Radiopharm; 2015 Mar; 30(2):87-93. PubMed ID: 25760728
[TBL] [Abstract][Full Text] [Related]
18. Different involvement of DNA methylation and histone deacetylation in the expression of solute-carrier transporters in 4 colon cancer cell lines.
Ikehata M; Ueda K; Iwakawa S
Biol Pharm Bull; 2012; 35(3):301-7. PubMed ID: 22382314
[TBL] [Abstract][Full Text] [Related]
19. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
Zhang Y; Fatima N; Dufau ML
Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
[TBL] [Abstract][Full Text] [Related]
20. Incubation with somatostatin, 5-aza decitabine and trichostatin up-regulates somatostatin receptor expression in prostate cancer cells.
Liu Z; Marquez M; Nilsson S; Holmberg AR
Oncol Rep; 2008 Jul; 20(1):151-4. PubMed ID: 18575731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
